NCT00704210

Brief Summary

Objective To demonstrate the effectiveness of a conservative treatment approach for chronic low back pain that addresses the underlying problem of intervertebral disc lesions and degenerative disc disease, namely vertebral pressure on vital structures of the lumbar region.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2006

Longer than P75 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

June 20, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2009

Completed
Last Updated

October 18, 2016

Status Verified

October 1, 2016

Enrollment Period

2.3 years

First QC Date

June 20, 2008

Last Update Submit

October 14, 2016

Conditions

Keywords

Low Back Pain

Outcome Measures

Primary Outcomes (3)

  • Pain will be measured using a 0-100 visual analog scale.

    19 weeks

  • Functional activity will be measured using the Roland Morris activity scale

    19 weeks

  • MRI outcome measures include thickness of disc (disc height, intervertebral space), extent of disc bulging, intervertebral alignment.

    19 weeks

Secondary Outcomes (5)

  • Physical and social activities and quality of life will be measured with the COOP

    19 weeks

  • Functional health will be measured with the SF-36

    19 weeks

  • Depression will be measured using the Geriatric Depression Scale (GDS)

    19 weeks

  • Treatment satisfaction will be measured using a 5-point Likert scale.

    19 weeks

  • Reduction in pain medication usage

    19 weeks

Study Arms (2)

B

SHAM COMPARATOR

Group B will receive sham decompression treatment (i.e. tension not exceeding 15 lbs) for 30 minutes and ice treatment for 15 minutes once a day during each treatment session. No incremental increases will be used for Group B.

Device: SpineMed Table, Cert HealthSciences LLC

A

EXPERIMENTAL

For Group A (the treated group) the following tension adjustments will be used: starting treatment tension will equal 1/4 body weight minus 10 lbs. Incremental increases of 4 lbs. per session will be implemented until optimum tensions are reached, which would be a maximum of ¼ body weight plus 25 lbs, unless distraction tensions cause discomfort, which would require a reduction of the tensions applied.

Device: SpineMed Table, Cert HealthSciences LLC

Interventions

For Group A (the treated group) the following tension adjustments will be used: starting treatment tension will equal 1/4 body weight minus 10 lbs. Incremental increases of 4 lbs. per session will be implemented until optimum tensions are reached, which would be a maximum of ¼ body weight plus 25 lbs, unless distraction tensions cause discomfort, which would require a reduction of the tensions applied.

A

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-specific LBP of at least 6 weeks duration with no evidence of underlying disease or anatomic abnormalities,
  • Applicants may have pain radiating to their legs.

You may not qualify if:

  • Any episode of Acute LBP within the last 6 weeks or less
  • Recent Fractures, less than 8 weeks of any bone
  • Tumors of any type including soft tissue tumors, myeloma, malignant or documented tumors of any type
  • Gross osteoporosis,
  • Spondylolisthesis grade 2 and above,
  • Hardware fixation, spine fixation or other boney fusion
  • Obesity as defined by a BMI greater than 35, body weight over 287 pounds,
  • Contra-indication for MRJ assessment,
  • Pregnancy,
  • neurologic deficits,
  • bowel or bladder incontinence,
  • progressive lower extremity weakness,
  • need for narcotic pain medications for other conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SUNY Upstate Medical University

Syracuse, New York, 13210, United States

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • William D Grant, EdD

    State University of New York - Upstate Medical University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Family Medicine

Study Record Dates

First Submitted

June 20, 2008

First Posted

June 24, 2008

Study Start

August 1, 2006

Primary Completion

December 1, 2008

Study Completion

July 1, 2009

Last Updated

October 18, 2016

Record last verified: 2016-10

Locations